Newsfeeds - Spark Newswire

2 minute read

CBD For Traumatic Brain Injuries? Oral Administration Reduces Levels Of Neuronal Death In Animal Model, New Study

Today, 7:12 AM

HempMeds, a subsidiary of Medical Marijuana, Inc. (OTCPK:MJNA) took part in a collaboration on a study to demonstrate the effectiveness of hemp-based CBD in the treatment of Parkinson's Disease.

MJNA

2 minute read

Medical Marijuana Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point

By Nina Zdinjak

Today, 7:12 AM

Cannabis company Medical Marijuana, Inc. (OTC: MJNA) announced Tuesday that its subsidiary HempMeds Brasil launched two new full spectrum products in Brazil.

MJNA

3 minute read

Argentina’s ‘Cannabis Conicet’ Public Company Seeks To Strengthen The Industry In South America

By Joana Scopel

Today, 7:12 AM

The government of Argentina created a technology company that aims to boost the medical cannabis and industrial hemp industry. The technology-based public company, the ‘Cannabis Conicet’, will operate under the direction of leading scientific researchers at the Arturo Jauretche Nat

MJNA

2 minute read

Medical Marijuana, Inc. Subsidiary HempMeds Mexico Undertakes Promising CBD Research For Parkinson’s Treatment

By Joana Scopel

Today, 7:12 AM

Cannabis company Medical Marijuana, Inc.

MJNA

2 minute read

Medical Marijuana Revenue Declines 18.75% YoY, Here Are The Details

By Vuk Zdinjak

Today, 7:12 AM

Medical Marijuana, Inc. (OTCPK:MJNA) released financial results for the quarter ending June 30, revealing net revenue of $7.8 million, a decrease of 18.75% compared to 9.6 million in Q2 2021. Q2 2022 Financial and Operational Highlights Gross profit for the period ending June 30, 2022, was $6 million.

MJNA

2 minute read

EXCLUSIVE: Medical Marijuana, Inc. Subsidiary HempMeds Working With Argentine Research Hospital On CBD For Adult Epilepsy

By Joana Scopel

Today, 7:12 AM

Medical Marijuana, Inc. (OTC: MJNA), the first publicly-traded cannabis company to launch cannabis-derived nutraceutical products, brands, and supply chains announced that its subsidiary HempMeds is collaborating with Hospital del Cruce to conduct a study in Argentina on the efficiency of CBD

MJNA

3 minute read

BREAKING: Brazil Supreme Court Authorizes Citizens To Grow Medicinal Cannabis

By Nicolas Jose Rodriguez

Today, 7:12 AM

What Happened?

AVCNF

2 minute read

Medical Marijuana Launches Pharma Subsidiary In Brazil, Expanding Access To CBD Products In Pharmacies

By Nina Zdinjak

Today, 7:12 AM

Medical Marijuana, Inc. (OTCPK: MJNA) has launched its first pharmaceutical subsidiary, HM Pharma, in Brazil.

MJNA

3 minute read

What’s The Future For Cannabis-Infused Edibles?

By Andrew Ward

Today, 7:12 AM

Cannabis-infused edibles are a booming market. The near-endless array of cannabinoid-rich foods and beverages are coupled with positive sales figures, suggesting that edibles should stick around as a market leader in the years to come.

CRLBF

1 minute read

Medical Marijuana, Inc. Reports Revenue Of $7.8M For Q1 2022

By Vuk Zdinjak

Today, 7:12 AM

Medical Marijuana, Inc. (OTCPK:MJNA) released its financial results for the quarter ending March 31, 2022, revealing $7.8 million in net revenue, a 24% increase when compared to the previous quarter. Q1 2022 Financial and Operational Highlights

AXIM